Preoperative lymphocyte-to-monocyte ratio represents a superior predictor compared with neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios for colorectal liver-only metastases survival

References

• ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
   PubMed Web of Science ®Google Scholar
• Van CutsemENordlingerBCervantesAESMO Guidelines Working GroupAdvanced colorectal cancer: ESMO Clinical Practice Guidelines for treatmentAnn Oncol201021Suppl 5v93v9720555112
   PubMed Web of Science ®Google Scholar
• O’ReillyDAPostonGJColorectal liver metastases: current and future perspectivesFuture Oncol20062452553116922619
   PubMedGoogle Scholar
• AkgulOCetinkayaEErsozSRole of surgery in colorectal cancer liver metastasesWorld J Gastroenterol201420206113612224876733
   PubMed Web of Science ®Google Scholar
• PrimroseJNSurgery for colorectal liver metastasesBr J Cancer201010291313131820424612
   PubMed Web of Science ®Google Scholar
• ViganoLCapussottiLLapointeREarly recurrence after liver resection for colorectal metastases: Risk factors, prognosis, and treatment. A LiverMetSurvey-based study of 6,025 patientsAnn Surg Oncol20142141276128624346766
   PubMed Web of Science ®Google Scholar
• ChanKMChiangJMLeeCFOutcomes of resection for colorectal cancer hepatic metastases stratified by evolving eras of treatmentWorld J Surg Oncol2011917422208884
   PubMed Web of Science ®Google Scholar
• ZlobecILugliAPrognostic and predictive factors in colorectal cancerJ Clin Pathol200861556156918326017
   PubMedGoogle Scholar
• MehrkhaniFNasiriSDonboliKMeysamieAHedayatAPrognostic factors in survival of colorectal cancer patients after surgeryColorectal Dis200911215716118462239
   PubMedGoogle Scholar
• DiakosCICharlesKAMcMillanDCClarkeSJCancer-related inflammation and treatment effectivenessLancet Oncol20141511e493e50325281468
   PubMed Web of Science ®Google Scholar
• LiuJGengQChenSNomogram based on systemic inflammatory response markers predicting the survival of patients with resectable gastric cancer after D2 gastrectomyOncotarget2016725375563756527121054
   PubMedGoogle Scholar
• RoxburghCSMcMillanDCRole of systemic inflammatory response in predicting survival in patients with primary operable cancerFuture Oncol20106114916320021215
   PubMed Web of Science ®Google Scholar
• ChuaWCharlesKABaracosVEClarkeSJNeutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancerBr J Cancer201110481288129521448173
   PubMed Web of Science ®Google Scholar
• YouJZhuGQXieLPreoperative platelet to lymphocyte ratio is a valuable prognostic biomarker in patients with colorectal cancerOncotarget2016718255162552727027440
   PubMedGoogle Scholar
• StotzMPichlerMAbsengerGThe preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancerBr J Cancer2014110243544024357796
   PubMed Web of Science ®Google Scholar
• NeofytouKSmythECGiakoustidisAKhanAZCunninghamDMudanSElevated platelet to lymphocyte ratio predicts poor prognosis after hepatectomy for liver-only colorectal metastases, and it is superior to neutrophil to lymphocyte ratio as an adverse prognostic factorMed Oncol2014311023925218270
   PubMedGoogle Scholar
• NeofytouKSmythECGiakoustidisAThe preoperative lymphocyte-to-monocyte ratio is prognostic of clinical outcomes for patients with liver-only colorectal metastases in the neoadjuvant settingAnn Surg Oncol201522134353436225773876
   PubMedGoogle Scholar
• FongYFortnerJSunRLBrennanMFBlumgartLHClinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive casesAnn Surg19992303309318 discussion 318–32110493478
   PubMed Web of Science ®Google Scholar
• LuZPengJWangZHigh preoperative serum CA19–9 level is predictive of poor prognosis for patients with colorectal liver oligometastases undergoing hepatic resectionMed Oncol2016331112127722895
   PubMedGoogle Scholar
• SchwarzLMichelPScotteMPredictive factors for the benefit of perioperative FOLFOX for resectable liver metastasis in colorectal cancer patients (EORTC Intergroup Trial 40983)Ann Surg20152611e28e2924263311
   PubMedGoogle Scholar
• ColottaFAllavenaPSicaAGarlandaCMantovaniACancer-related inflammation, the seventh hallmark of cancer: links to genetic instabilityCarcinogenesis20093071073108119468060
   PubMed Web of Science ®Google Scholar
• ParkJHWattDGRoxburghCSHorganPGMcMillanDCColorectal cancer, systemic inflammation, and outcome: Staging the tumor and staging the hostAnn Surg2016263232633625575264
   PubMed Web of Science ®Google Scholar
• ShibutaniMMaedaKNagaharaHSignificance of markers of systemic inflammation for predicting survival and chemotherapeutic outcomes and monitoring tumor progression in patients with unresectable metastatic colorectal cancerAnticancer Res20153595037504626254405
   PubMed Web of Science ®Google Scholar
• GuLLiHChenLPrognostic role of lymphocyte to monocyte ratio for patients with cancer: Evidence from a systematic review and meta-analysisOncotarget2016722319263194226942464
   PubMedGoogle Scholar
• ChanJCChanDLDiakosCIThe Lymphocyte-to-Monocyte ratio is a superior predictor of overall survival in comparison to established biomarkers of resectable colorectal cancerAnn Surg2017265353954627070934
   PubMed Web of Science ®Google Scholar
• ShibutaniMMaedaKNagaharaHPrognostic significance of the lymphocyte-to-monocyte ratio in patients with metastatic colorectal cancerWorld J Gastroenterol201521349966997326379401
   PubMed Web of Science ®Google Scholar
• LinGNLiuPPLiuDYPengJWXiaoJJXiaZJPrognostic significance of the pre-chemotherapy lymphocyte-to-monocyte ratio in patients with previously untreated metastatic colorectal cancer receiving FOLFOX chemotherapyChin J Cancer201635526740116
   PubMedGoogle Scholar
• OzawaTIshiharaSKawaiKImpact of a lymphocyte to monocyte ratio in stage IV colorectal cancerJ Surg Res2015199238639226163330
   PubMed Web of Science ®Google Scholar
• LinEYPollardJWRole of infiltrated leucocytes in tumor growth and spreadBr J Cancer200490112053205815164120
   PubMedGoogle Scholar
• DunnGPOldLJSchreiberRDThe immunobiology of cancer immunosurveillance and immunoeditingImmunity200421213714815308095
   PubMed Web of Science ®Google Scholar
• MengesTEngelJWeltersIChanges in blood lymphocyte populations after multiple trauma: Association with posttraumatic complicationsCrit Care Med199927473374010321662
   PubMed Web of Science ®Google Scholar
• LiangLZhuJJiaHPredictive value of pretreatment lymphocyte count in stage II colorectal cancer and in high-risk patients treated with adjuvant chemotherapyOncotarget2016711014102826510910
   PubMedGoogle Scholar
• QianBZLiJZhangHCCL2 recruits inflammatory monocytes to facilitate breast-tumor metastasisNature2011475735522222521654748
   PubMed Web of Science ®Google Scholar
• MovahediKLaouiDGysemansCDifferent tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytesCancer Res201070145728573920570887
   PubMed Web of Science ®Google Scholar
• CondeelisJPollardJWMacrophages: Obligate partners for tumor cell migration, invasion, and metastasisCell2006124226326616439202
   PubMed Web of Science ®Google Scholar
• RogersTLHolenITumor macrophages as potential targets of bisphosphonatesJ Transl Med2011917722005011
   PubMed Web of Science ®Google Scholar
• Di CaroGCorteseNCastinoGFDual prognostic significance of tumor-associated macrophages in human pancreatic adenocarcinoma treated or untreated with chemotherapyGut201665101710172026156960
   PubMedGoogle Scholar
• SteidlCLeeTShahSPTumor-associated macrophages and survival in classic Hodgkin’s lymphomaN Engl J Med20103621087588520220182
   PubMed Web of Science ®Google Scholar